PMID: 6111260Jan 1, 1980Paper

3H]-dopamine release from the rabbit retina

Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology
B BauerL Aberg

Abstract

[3H]-Dopamine was found to be released from the rabbit retina in vitro by light stimulation, by 40 mM K+, and by alpha-MSH (alpha-Melanocyte-Stimulating Hormone) down to about 10(-7) M. The effect of alpha-MSH was dose-dependent. A number of known and putative retinal neurotransmitters and agonists (GABA, muscimol, glutamic acid, kainic acid, glycine, and carbachol, all 10(-4) M) were without significant effect. The results show that it is unlikely that there are excitatory receptors on the retinal dopaminergic neurons to any of the conventional transmitters. Further, alpha-MSH seems of interest as a possible neuroactive retinal substance, which was previously not been suspected.

References

Dec 2, 1975·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·B B BoycottA M Laties
Apr 13, 1978·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·W L Hedden, J E Dowling
Apr 13, 1978·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·J E Dowling, B Ehinger
Jul 1, 1979·The Journal of Pharmacy and Pharmacology·R W Kerwin, C J Pycock
Oct 1, 1979·The Journal of Cell Biology·R H Masland, J W Mills
Mar 1, 1975·Vision Research·M MurakamiH Shimazaki
May 6, 1975·Naunyn-Schmiedeberg's Archives of Pharmacology·M B Bucher, M Schorderet
Jul 15, 1978·The Journal of Comparative Neurology·J E Dowling, B Ehinger
Dec 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D M Jacobowitz, T L O'Donohue
Mar 19, 1979·Cell and Tissue Research·B Ehinger, I Holmgren
Jan 1, 1979·The Journal of Physiology·J G HallH V Wheal
Nov 15, 1977·European Journal of Pharmacology·J C Stoof, A H Mulder
Jan 6, 1978·Brain Research·M F GiorguieffM J Besson
Jan 15, 1978·European Journal of Pharmacology·A ChéramyJ Glowinski
Oct 13, 1978·Brain Research·D MacNeilI Szymanska
May 23, 1969·Zeitschrift für Zellforschung und mikroskopische Anatomie·B EhingerA M Laties
Apr 1, 1972·Vision Research·M J Voaden, M S Starr
Aug 1, 1951·The Japanese Journal of Physiology·T HANAOKA

❮ Previous
Next ❯

Citations

Jan 1, 1989·Journal of Neural Transmission·J Z Nowak, E Zurawska
Jan 1, 1981·Vision Research·B BauerK Tornqvist
Jan 1, 1983·Vision Research·R J Jensen, N W Daw
Jan 1, 1987·Vision Research·M J JaffeF M de Monasterio
Apr 1, 1990·Journal of Neuroscience Methods·C J Gibson
Feb 1, 1992·Neurochemistry International·M B Djamgoz, H J Wagner
Nov 1, 1996·Journal of Chemical Neuroanatomy·B BjelkeK Fuxe
Mar 1, 2005·Visual Neuroscience·Jianguo XiaoDavid Marshak
Aug 23, 2007·Visual Neuroscience·Stephen L MillsDavid W Marshak
Sep 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Dao-Qi ZhangDouglas G McMahon
Jan 1, 1990·Annals of the New York Academy of Sciences·M L Dubocovich
Oct 2, 2012·Journal of Neuroscience Research·Jinnan YangGuo-Yong Wang
Nov 13, 1992·Brain Research·C J Gibson
Feb 18, 1999·The Journal of Comparative Neurology·D Xin, S A Bloomfield
Jun 22, 1987·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·S C Mangel, J E Dowling
Oct 1, 1985·Acta Ophthalmologica·B BauerJ Waga
Feb 7, 2019·Journal of Neurophysiology·Reece E MazadeErika D Eggers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.